Welcome to LookChem.com Sign In|Join Free
  • or
4-Amino-2-(trifluoromethyl)quinoline is a chemical compound with the molecular formula C10H7N2F3. It is a derivative of quinoline, a heterocyclic aromatic compound, featuring an amino group at the 4-position and a trifluoromethyl group at the 2-position. 4-Amino-2-(trifluoromethyl)quinoline is known for its potential applications in the synthesis of pharmaceuticals and agrochemicals, particularly as an intermediate in the production of various biologically active molecules. Its unique structure, with the electron-withdrawing trifluoromethyl group and the electron-donating amino group, contributes to its reactivity and utility in organic synthesis. The compound is typically synthesized through various chemical reactions and can be used in the development of new drugs and pesticides, highlighting its importance in the field of medicinal chemistry.

1700-93-2

Post Buying Request

1700-93-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1700-93-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1700-93-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,7,0 and 0 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1700-93:
(6*1)+(5*7)+(4*0)+(3*0)+(2*9)+(1*3)=62
62 % 10 = 2
So 1700-93-2 is a valid CAS Registry Number.

1700-93-2Relevant academic research and scientific papers

Synthesis of aryl-heteroaryl ureas (AHUs) based on 4-aminoquinoline and their evaluation against the insulin-like growth factor receptor (IGF-1R)

Engen, William,O'Brien, Terrence E.,Kelly, Brendan,Do, Jacinda,Rillera, Liezel,Stapleton, Lance K.,Youngren, Jack F.,Anderson, Marc O.

experimental part, p. 5995 - 6005 (2010/09/30)

The insulin-like growth factor receptor (IGF-1R) is a receptor tyrosine kinase (RTK) involved in all stages of the development and propagation of breast and other cancers. The inhibition of IGF-1R by small molecules remains a promising strategy to treat cancer. Herein, we explore SAR around previously characterized lead compound (1), which is an aryl-heteroaryl urea (AHU) consisting of 4-aminoquinaldine and a substituted aromatic ring system. A library of novel AHU compounds was prepared based on derivatives of the 4-aminoquinoline heterocycle (including various 2-substituted derivatives, and naphthyridines). The compounds were screened for in vitro inhibitory activity against IGF-1R, and several compounds with improved activity (3-5 μM) were identified. Furthermore, a computational docking study was performed, which identifies a fairly consistent lowest energy mode of binding for the more-active set of inhibitors in this series, while the less-active inhibitors do not adopt a consistent mode of binding.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1700-93-2